Tocqueville Asset Management L.P. Lowers Holdings in AdaptHealth Corp. $AHCO

Key Points

• Tocqueville Asset Management L.P. has reduced its stake in AdaptHealth Corp. by 7.9% during the first quarter, now holding 348,000 shares valued at approximately $3.77 million.
• Several institutional investors have increased their holdings in AdaptHealth, with GAMMA Investing LLC raising its stake by 175.2% in the same quarter.
• AdaptHealth currently has a consensus rating of "Buy" from six research analysts, with an average target price of $13.40.

Tocqueville Asset Management L.P. reduced its holdings in shares of AdaptHealth Corp. (NASDAQ:AHCO - Free Report) by 7.9% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 348,000 shares of the company's stock after selling 30,000 shares during the period. Tocqueville Asset Management L.P. owned about 0.26% of AdaptHealth worth $3,772,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also bought and sold shares of the company. GAMMA Investing LLC grew its position in AdaptHealth by 175.2% during the first quarter. GAMMA Investing LLC now owns 7,473 shares of the company's stock valued at $81,000 after acquiring an additional 4,758 shares during the last quarter. Oppenheimer Asset Management Inc. grew its position in AdaptHealth by 6.8% during the first quarter. Oppenheimer Asset Management Inc. now owns 32,797 shares of the company's stock valued at $356,000 after acquiring an additional 2,081 shares during the last quarter. New York State Teachers Retirement System grew its position in AdaptHealth by 3.3% during the first quarter. New York State Teachers Retirement System now owns 80,455 shares of the company's stock valued at $872,000 after acquiring an additional 2,600 shares during the last quarter. Janus Henderson Group PLC grew its holdings in shares of AdaptHealth by 42.9% in the fourth quarter. Janus Henderson Group PLC now owns 38,298 shares of the company's stock worth $364,000 after purchasing an additional 11,500 shares during the last quarter. Finally, Janney Montgomery Scott LLC bought a new position in shares of AdaptHealth in the first quarter worth approximately $854,000. 82.67% of the stock is currently owned by institutional investors.

AdaptHealth Stock Up 4.2%

AdaptHealth stock traded up $0.3950 on Friday, hitting $9.7150. 695,072 shares of the stock traded hands, compared to its average volume of 1,426,099. The company has a current ratio of 1.06, a quick ratio of 0.82 and a debt-to-equity ratio of 1.14. The firm has a market cap of $1.31 billion, a P/E ratio of 17.99, a price-to-earnings-growth ratio of 1.04 and a beta of 1.58. The business's fifty day simple moving average is $9.20 and its 200 day simple moving average is $9.25. AdaptHealth Corp. has a 1 year low of $7.11 and a 1 year high of $11.70.

Analyst Upgrades and Downgrades

AHCO has been the topic of several recent analyst reports. Wall Street Zen upgraded shares of AdaptHealth from a "hold" rating to a "buy" rating in a report on Saturday, August 9th. Truist Financial cut their target price on shares of AdaptHealth from $14.00 to $13.00 and set a "buy" rating on the stock in a report on Monday, May 12th. Finally, Royal Bank Of Canada cut their price target on shares of AdaptHealth from $14.00 to $13.00 and set an "outperform" rating on the stock in a report on Thursday, May 8th. Five research analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, AdaptHealth currently has an average rating of "Buy" and an average price target of $13.40.

About AdaptHealth

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.